Crossmark

A brighter future for the implementation of pharmacogenomic testing

Crossref DOI link: https://doi.org/10.1038/ejhg.2016.116

Published Online: 2016-08-31

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

van der Wouden, Cathelijne H

Swen, Jesse J

Samwald, Matthias

Mitropoulou, Christina

Schwab, Matthias

Guchelaar, Henk-Jan
License Information

Text and Data Mining valid from 2016-08-31
More Information

Article History

Received: 30 June 2016

Revised: 5 July 2016

Accepted: 22 July 2016

First Online: 31 August 2016

Competing interests

: Matthias Schwab is the contributor to patents related to TPMT. The remaining authors declare no conflict of interest.